For the quarter ending 2026-03-31, CPRX made $149,390K in revenue. $63,742K in net income. Net profit margin of 42.67%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 149,390 | 152,613 | 148,392 | 146,563 |
| Cost of sales | 14,475 | 26,074 | 22,654 | 20,614 |
| Research and development | 2,661 | 1,807 | 2,657 | 4,358 |
| Selling, general and administrative | 49,319 | 53,421 | 47,470 | 45,949 |
| Amortization of intangible assets | 9,703 | 9,465 | 9,344 | 9,344 |
| Total operating costs and expenses | 76,158 | 90,767 | 82,125 | 80,265 |
| Operating income | 73,232 | 61,846 | 66,267 | 66,298 |
| Other income, net | 10,997 | 10,055 | 4,768 | 2,995 |
| Net income before income taxes | 84,229 | 71,901 | 71,035 | 69,293 |
| Income tax provision | 20,495 | 19,203 | 18,252 | 17,185 |
| Net income | 63,734 | 52,698 | 52,783 | 52,108 |
| Unrealized gain (loss) on available-for-sale securities, net of tax of (3) and 25, respectively | 8 | 0 | -31 | 48 |
| Comprehensive income | 63,742 | 52,698 | 52,752 | 52,156 |
| Basic EPS | 0.52 | 0.429 | 0.43 | 0.43 |
| Diluted EPS | 0.5 | 0.414 | 0.42 | 0.41 |
| Basic Average Shares | 122,254,171 | 122,927,054 | 122,600,730 | 122,163,212 |
| Diluted Average Shares | 126,903,391 | 127,440,256 | 127,090,194 | 127,543,284 |
CATALYST PHARMACEUTICALS, INC. (CPRX)
CATALYST PHARMACEUTICALS, INC. (CPRX)